The 2017 ACIP Adult Immunization Schedule appeared in Annals of Internal Medicine and on the Centers for Disease Control and Prevention Web site.
Changes in the 2017 adult immunization schedule from the previous year's schedule include new or revised ACIP recommendations on influenza, human papillomavirus, hepatitis B, and meningococcal vaccinations.
The updated changes include people with HCV;
The ACIP updated chronic liver disease conditions for which a hepatitis B vaccine (HepB) series is recommended. This change is described in the 2017 adult immunization schedule as:
Adults with chronic liver disease, including, but not limited to, hepatitis C virus infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, and an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level greater than twice the upper limit of normal, should receive a HepB series.
Listen to key changes in this podcast available at Medscape;
ACIP 2017 Immunization Schedule: The Key Points
Updated ACIP Recommendations Nix LAIV, Expand HBV Vaccination
CDC Web Site
Immunization schedule is available at the CDC's web site for; Adults -19 years and older, and children/adolescents 18 years or younger.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
February 7, 2017
In October 2016, the Advisory Committee on Immunization Practices (ACIP) voted to approve the Recommended Adult Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017. Changes in the 2017 adult immunization schedule from the previous year’s schedule include new or revised ACIP recommendations for influenza, human papillomavirus, hepatitis B, and meningococcal vaccines.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017
February 7, 2017
In October 2016, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger—United States, 2017. Changes in the 2017 immunization schedules for children and adolescents aged 18 years or younger include new or revised ACIP recommendations for influenza; human papillomavirus; hepatitis B; Haemophilus influenzae type B; pneumococcal; meningococcal; and diphtheria and tetanus toxoids and acellular pertussis vaccines.
In The Media
What you need know about the CDC's updated vaccine guidelines
Roll up your sleeves, America. A national advisory panel of the U.S. Centers for Disease Control and Prevention has released its 2017 advisory for recommended shots affecting adults.
Too few U.S. teens getting flu and cancer vaccines
(Reuters Health) - Less than half of U.S. adolescents get vaccinated to protect against seasonal influenza, and even fewer teens receive shots to help prevent cancers of the cervix and throat, new research suggests.
- Newly Diagnosed
- All FDA Approved Drugs To Treat Hepatitis C
- 2017-HCV Genotypes/Treatment
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Not FDA Approved - Sofosbuvir/Velpatasvir/Voxilaprevir
- Not FDA Approved - Glecaprevir/Pibrentasvir (G/P)
- NOT FDA Approved - MK3 (MK-3682/grazoprevir/ruzasvir1)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- Treating Elderly HCV Patients
- FibroScan® Understanding The Results
- Staging Cirrhosis
- Is There A Natural Way To Improve Liver Fibrosis?